/manager/Index ${session.getAttribute("locale")} 5 Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC Study /manager/Repository/uon:11225 Sat 24 Mar 2018 08:11:14 AEDT ]]> Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen /manager/Repository/uon:11170 Sat 24 Mar 2018 08:10:42 AEDT ]]> Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial /manager/Repository/uon:11140 Sat 24 Mar 2018 08:10:29 AEDT ]]> Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the arimidex, tamoxifen alone or in combination trial /manager/Repository/uon:17517 Sat 24 Mar 2018 08:03:50 AEDT ]]>